Evidence map›Paper›PMID 32520771›Full record

ArticleJournal of the Chinese Medical Association : JCMA2020

A novelty route for smartphone-based artificial intelligence approach to ophthalmic screening.

Ying-Chun Jheng, Yu-Bai Chou, Chung-Lan Kao, Aliaksandr A Yarmishyn, Chih-Chien Hsu, Tai-Chi Lin, Po-Yin Chen, Zih-Kai Kao, Shih-Jen Chen, De-Kuang Hwang

Abstract read
In one paragraph

Article in Journal of the Chinese Medical Association : JCMA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. LinguAPP: An m-Health Application for Teledentistry Diagnostics.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ying-Chun JhengDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Yu-Bai ChouDepartment of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Chung-Lan KaoDepartment of Physical Medicine & Rehabilitation, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Aliaksandr A YarmishynDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Chih-Chien HsuDepartment of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Tai-Chi LinDepartment of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Po-Yin ChenDepartment of Physical Medicine & Rehabilitation, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Zih-Kai KaoDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Shih-Jen ChenDepartment of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
De-Kuang HwangDepartment of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) has been widely applied in the medical field and achieved enormous milestones in helping specialists to make diagnosis and remedy decisions, particularly in the field of eye diseases and ophthalmic screening. With the development of AI-based systems, the enormous hardware and software resources are required for optimal performance. In reality, there are many places on the planet where such resources are highly limited. Hence, the smartphone-based AI systems can be used to provide a remote control route to quickly screen eye diseases such as diabetic-related retinopathy or diabetic macular edema. However, the performance of such mobile-based AI systems is still uncharted territory. In this article, we discuss the issues of computing resource consumption and performance of the mobile device-based AI systems and highlight recent research on the feasibility and future potential of application of the mobile device-based AI systems in telemedicine.

Indexed as

Artificial IntelligenceSmartphoneTelemedicineEye DiseasesHumans

Identifiers

PMID32520771
PMCPMC7526562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.